Cytotect®CP as salvage therapy in patients with CMV infection following allogeneic hematopoietic cell transplantation: a multicenter retrospective study-Reference-Cited by-同舟云学术

Cytotect®CP as salvage therapy in patients with CMV infection following allogeneic hematopoietic cell transplantation: a multicenter retrospective study

Published:2018-04-13 Issue:10 Volume:53 Page:1328-1335
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Alsuliman Tamim,Kitel Caroline,Dulery Rémy,Guillaume Thierry,Larosa Fabrice,Cornillon Jérôme,Labussière-Wallet Helene,Médiavilla Clémence,Belaiche Stéphanie,Delage Jeremy,Alain Sophie,Yakoub-Agha Ibrahim

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-018-0166-9.pdf

Reference47 articles.

1. Chevallier P, Szydlo RM, Blaise D, Tabrizi R, Michallet M, Uzunov M. et al. Reduced-intensity conditioning before allogeneic hematopoietic stem cell transplantation in patients over 60 years: a report from the SFGM-TC. Biol Blood Marrow Transplant. 2012;18:289–94.S1083-8791(11)00303-X [pii] 10.1016/j.bbmt.2011.07.013.

2. Damaj G, Duhamel A, Robin M, Beguin Y, Michallet M, Mohty M. et al. Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Societe Francaise de Greffe de Moelle et de Therapie-Cellulaire and the Groupe-Francophone des Myelodysplasies. J Clin Oncol. 2012;30:4533–40.10.1200/JCO.2012.44.3499.

3. Depil S, Deconinck E, Milpied N, Sutton L, Witz F, Jouet JP. et al. Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome. Bone Marrow Transplant. 2004;33:531–4.10.1038/sj.bmt.1704381 1704381 [pii].

4. Ustun C, Reiter A, Scott BL, Nakamura R, Damaj G, Kreil S. et al. Hematopoietic stem-cell transplantation for advanced systemic mastocytosis. J Clin Oncol. 2014;32:3264–74.10.1200/JCO.2014.55.2018.

5. Nguyen S, Chalandon Y, Lemarie C, Simon S, Masson D, Dhedin N. et al. [Haploidentical hematopoietic stem cell transplantation: guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)]. Bull Cancer. 2016;103(11S):S229–S242.S0007-4551(16)30220-X [pii] 10.1016/j.bulcan.2016.09.007.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-CMV therapy, what next? A systematic review;Frontiers in Microbiology;2023-11-20

2. Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management. A report from the CMV International Symposium 2023;Transplant Infectious Disease;2023-11-09

3. Single-cell analysis of memory B cells from top neutralizers reveals multiple sites of vulnerability within HCMV Trimer and Pentamer;Immunity;2023-11

4. CMV hyperimmune globulin as salvage therapy for recurrent or refractory CMV infection in children undergoing hematopoietic stem cell transplantation;Frontiers in Pediatrics;2023-07-24

5. Neutralization Epitopes in Trimer and Pentamer Complexes Recognized by Potent Cytomegalovirus-Neutralizing Human Monoclonal Antibodies;Microbiology Spectrum;2022-12-21